Chemed Reports Third-Quarter 2026 Results
CHEMED CORP (CHE) filed an SEC Form 8-K — Results of Operations and Financial Condition. CONTACT: Michael D. Witzeman (513) 762- 6714 Chemed Reports Third-Quarter 2026 Results CINCINNATI, October 27, 2026— Chemed Corporation (Chemed) (NYSE: CHE ), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto
How this was made
The 30-second read
Why it matters
The earnings beat reinforces Chemed's growth narrative and may trigger buying interest, especially in the VITAS segment.
Market read
First‑time disclosure of Q3 2026 earnings for a mid‑cap U.S. stock; material financial improvements suggest a bullish short‑term outlook.
What to watch
Medicare Cap reductions and higher debt levels could pressure cash flow in the longer term.
Background
Chemed Corp operates VITAS Healthcare, the largest end‑of‑life care provider, and Roto‑Rooter, a leading plumbing services firm.
Ticker impact
Chemed Corp reported Q3 2026 results with revenue up 10.6% to $690.9M and GAAP EPS of $5.45, a 22.2% increase.
likely upside as investors price in better‑than‑expected earnings and higher guidance.
Revenue and EPS growth are material and disclosed for the first time; the scale of the company and the magnitude of the beat support a confident positive impact.
Market effects
Positive earnings may lift healthcare services and plumbing/maintenance sector sentiment.
U.S. investors may see modest gains in related mid‑cap stocks.
Limited to U.S. markets; no direct global macro effect.
Counterpoint
Roto‑Rooter segment margin declined and net income fell, suggesting potential headwinds despite overall growth.
Key entities
- companyChemed Corp
Parent company of VITAS Healthcare and Roto‑Rooter.
- segmentVITAS Healthcare
End‑of‑life care provider contributing $457.4M net patient revenue.
- segmentRoto‑Rooter
Plumbing and drain cleaning services generating $233.5M revenue.
